Introduction
Basal cell carcinoma is the most common cutaneous malignant tumor directly related to sunlight and UV radiation exposure. A number of histopathological subtypes of basal cell carcinoma have been defined. Among these subtypes, clear cell basal cell carcinoma is a rare variant composed of tumor cells with prominent cytoplasmic vacuoles or signet ring morphology. The pathogenesis of this variant, however, remains unclear. Distinguishing among basal cell variants as well as differentiating it from other clear cell tumors is important because treatment and prognosis of each may vary.
Case Presentation
A 65-year-old male presented with a 0.9 cm dome-shaped dark lesion on his upper chest. The clinical impression was basal cell carcinoma versus recurrent dysplastic nevus. The shave biopsy specimen showed a dermal tumor that comprised nests of basaloid cells with a peripheral palisading pattern and retraction artifacts (Figures 1 and 2 ).
The basaloid cells were mitotically active, and apoptotic bodies were noted. The basaloid neoplasm manifested all features of ordinary basal cell carcinoma. However, striking clear cell changes were observed in the center of large nests ( Figure 2 ). The clear cells were striking in appearance with a single large vacuole in their cytoplasm and a dark, condensed nucleus at the periphery. There were no clear cells with foamy-bubbly cytoplasm or starry nuclei; when present, this finding is typical of sebaceous cells. There were no clear pagetoid cells in the overlying epidermis. PAS staining was positive for the presence of glycogen ( Figures  3 and 4) , but no mucin was identified by mucicarmine stain. Immunohistochemical studies showed positive staining for EMA ( Figure 5 ), Bcl-2 ( Figure 6 ), CK5/6, and high molecular weight keratin but not for S 100 or vimentin. Ki-67 staining of the clear cells ( Figure 7 ) was negative compared to the positive staining of a typical nodular basal cell carcinoma (Figure 8 The lesion was completely excised with clear margins. Three years later, the patient remains free of any recurrence.
Discussion
Basal cell carcinoma (BCC) is the most common skin cancer, accounting for approximately 80% of nonmelanoma skin cancers. BCC usually occurs in sun exposed areas of the skin, most often the head and neck (80%), followed by the trunk (15%), and extremities [1] . Risk factors for developing BCC include exposure to ultraviolet radiation, a fair complexion, and immunosuppression. The clinical presentation can be quite variable, but lesions are typically described as shiny, pearly papules or nodules with a rolled border that may exhibit crusting, ulceration, or bleeding.
BCC is thought to arise from pluripotential cells in the basal layer of the epidermis that are capable of differentiating into hair, sebaceous glands, or sweat glands. Perhaps as a consequence, there is considerable histopathologic variation among basal cell tumors, and several subtypes in classifying BCC subtypes is that there appears to be a correlation between the histologic subtype and the clinical behavior. Micronodular, infiltrative, basosquamous, and morpheaform subtypes are more aggressive, while nodular and superficial types are less aggressive [3] .
Clear cell basal cell carcinoma was first described by Barr and Williamson in 1984 [4] . A review of the literature to date reveals a total of 32 reported cases since that first description. Histochemical observations between cases have been inconsistent. PAS staining with and without diastase has been positive for glycogen in some cases [4] [5] [6] but not in others [7] [8] [9] [10] . One report noted the presence of sialomucin deposition [6] constituting about 3% of the reported cases. Electron microscopic studies have also been variable, as some have observed the large intracellular vacuoles to be membrane bound [10, 11] , while others have not [5, 7, 9] .
The differential diagnosis of clear cell basal cell carcinoma includes sebaceous carcinoma, clear cell squamous cell carcinoma, eccrine porocarcinoma, hidroadenocarcinoma, trichilemmal carcinoma, clear cell melanoma, and metastatic clear cell renal carcinoma. Sebaceous carcinoma cells with "foamy-bubbly" cytoplasm are positive for lipid on staining with Oil Red O or Sudan IV on frozen tissue and are Because the clear cells of clear cell BCC stain positive for glycogen, the pathogenesis was initially suggested to be due to trichilemmal differentiation [4] . Subsequent hypothesis have suggested that the large, clear membrane-bound vacuoles are phagolysosomes containing degradation products of intracellular organelles [7, 10] . However, the underlying mechanisms responsible for this histologic subtype of BCC are unknown.
Conclusion
Clear cell BCC is a rare and unusual variant of BCC. The underlying pathogenesis, clinical effect on treatment, and prognosis of this subtype remain unclear.
